Lupin dips 5% on USFDA warning letter for Somerset manufacturing unit

Shares of Lupin dipped 5 per cent to Rs 1,173 on the BSE in intra-day trade on Monday after the pharmaceutical company said it has received a Warning Letter (WL) for its manufacturing plant at Somerset, New Jersey. This is the only manufacturing plant of Lupin located in the US.

However, Lupin said the company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility.

At 09:57 am, Lupin was trading 3 per cent lower at Rs 1,194, as compared to 0.37 per cent